1. Home
  2. TOVX vs FTHM Comparison

TOVX vs FTHM Comparison

Compare TOVX & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

SELL

Current Price

$0.21

Market Cap

11.1M

Sector

Health Care

ML Signal

SELL

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

HOLD

Current Price

$0.19

Market Cap

11.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOVX
FTHM
Founded
2001
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
11.4M
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
TOVX
FTHM
Price
$0.21
$0.19
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.50
N/A
AVG Volume (30 Days)
373.1K
★ 1.5M
Earning Date
08-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 89.07
32.71
EPS
★ N/A
N/A
Revenue
N/A
★ $420,477,000.00
Revenue This Year
N/A
$9.48
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 25.45
52 Week Low
$0.16
$0.18
52 Week High
$0.85
$1.84

Technical Indicators

Market Signals
Indicator
TOVX
FTHM
Relative Strength Index (RSI) 40.19 19.74
Support Level $0.17 N/A
Resistance Level $0.25 $0.92
Average True Range (ATR) 0.01 0.04
MACD -0.00 -0.01
Stochastic Oscillator 2.05 2.57

Price Performance

Historical Comparison
TOVX
FTHM

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.

Share on Social Networks: